Ministero della Salute

Size: px
Start display at page:

Download "Ministero della Salute"

Transcription

1 Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2010 RICERCA FINALIZZATA E GIOVANI RICERCATORI Standardizing tissue handling in pre analytical procedures: technological, environmentally safe innovation in solid tumour processing. Piemonte CLI Healthcare Delivery and Development of new IVD CE molecular diagnostic tests for the detection of epigenetic defects involved in human disease MAGGIORE BIO Genes, Genomes and Genetics (1) Nerve Growth Factor eye drops as a novel treatment for vision loss in patients with Retinitis Pigmentosa: from preclinical to clinical Phase II trial. SAN RAFFAELE MONTE TABOR CLI Brain Disorders and IMMUNOLOGICAL IMPACT OF SILIBININ TREATMENT FOR HCV RECURRENCE IN STABLE LIVER TRANSPLANTED PATIENTS Puglia CLI Immunology Planar haptic device and virtual reality tools for hand and finger rehabilitation S.CAMILLO CLI Musculoskeletal, Oral and UNRESECTABLE IN TRANSIT METASTATIC MELANOMA: ELECTROCHEMO THERAPY VERSUS ELECTROIMMUNOTHERAPY. LOCAL AND SYSTEMIC EFFECTS. PASCALE CLI Oncology 2 Translational 8, Hyperthophic cardiomyopathy: new insights from deep sequencing and psycosocial evaluation. Lombardia CLI Cardiovascular and 8, Pagina 1 di 6

2 CERVICAL PLETHYSMOGRAPHY: A NEW TOOL FOR NON INVASIVE ASSESSMENT OF CEREBRAL VENOUS RETURN, AND A POSSIBLE SCREENING DEVICE FOR CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY Emilia Romagna CLI Vascular and Hematology Porous titanium combined with an osteoinductive hydrogel and cells: an innovative strategy to improve prosthetic implants osteointegration GALEAZZI BIO Musculoskeletal, Oral and Improved pre surgical evaluation of the human epileptogenic zone with a novel intracranial recording/analysis platform CARLO BESTA BIO Brain Disorders and 9, Role of SAMITAL in prevention of chemo radiation (CT/RT) induced oral mucositis in cancer patients. A Phase 2 Randomized Controlled trial in adults and a feasibility study in paediatric patients I. O. V. CLI Oncology 2 Translational Cancer biomarker detection using microstructured/super hydrophobic surfaces and advanced spectroscopy techniques Calabria BIO Bioengineering Sciences and Technologies Development and optimization of a dedicated selfshielded system to perform accelerated partial breast irradiation in prone position after breast conserving surgery. REGINA ELENA CLI Oncology 2 Translational Development of brain targeted epigenetic drugs for the treatment of neurodegenerative disorders and brain ischemia S.CAMILLO BIO Brain Disorders and Cost Utility of Conventional Hemodialysis (CHD) versus Short Daily Hemodialysis (SDHD) for patients coming from Automated Peritoneal Dialysis (APD): A randomized controlled trial Puglia CLI Healthcare Delivery and A new automatic device for personalized clinical monitoring of thrombotic and hemorraghic risk assessment in cancer patients C.R.O. AVIANO BIO Oncology 2 Translational Pagina 2 di 6

3 Docetaxel, Cisplatin and 5 Fluorouracil followed by concomitant Radiotherapy and PF in Locally advanced Head and Neck carcinoma: A phase II study proposal Lombardia CLI Oncology 2 Translational 10, (1) ß amyloid control of peripheral and neuronal glucose uptake NEUROMED BIO Brain Disorders and 10, DOSE WARPING METHODS FOR IGRT AND ADAPTIVE RT: DOSE ACCUMULATION BASED ON ORGAN MOTION AND ANATOMICAL VARIATIONS OF THE PATIENTS DURING RADIATION THERAPY TREATMENTS Emilia Romagna BIO Oncology 2 Translational 10, FREMS for Acute Inflammatory Bowel Disease: a Phase I/II trial Lazio CLI Digestive, Kidney and Urological Systems 10, Sebum lipidomics: a new tool to correlate skin and systemic lipid metabolism. SAN GALLICANO BIO Musculoskeletal, Oral and Use of a new material (polipropilene biofilm) with coated nanoparticles for the release of antibacterial drugs instead of surgical mesh for the reconstructive surgery of pelvic floor. Lazio BIO Digestive, Kidney and Urological Systems A Phase II Randomized Multicentre Study of SystemicChemotherapy versus Systemic Chemotherapy plus SIR Spheres as SecondLine in KRAS Mutant Unresectable Colorectal Liver Metastases (SITILO 2) Lazio CLI Oncology 2 Translational GOAL DIRECTED PERFUSION AND ACUTE KIDNEY INJURY IN CARDIAC SURGERY A RANDOMIZED, CONTROLLED TRIAL SAN DONATO CLI Surgical Sciences, Biomedical Imaging, and Bioengineering Metabotropic glutamate receptors as a target for the treatment of Amyotrophic Lateral Sclerosis NEUROMED BIO Brain Disorders and Pagina 3 di 6

4 Phase II trial of fulvestrant and gefitinib combination in patients with EGFR mutations who failed a first line with EGFR Tyrosine Kinase Inhibitors (TKIs) ISTITUTO TUMORI MILANO CLI Oncology 2 Translational Integrated lipidomic profiling in diabetes, cardiovascular disease and cancer in a cohort of subjects in a mediterranean area of southern Italy: a nested case control study. DE BELLIS BIO Population Sciences and Epidemiology Haemophilia arthropathy (HA) and Ultrasound (US): development and first validation steps of the simplified HEAD US score Liguria CLI Musculoskeletal, Oral and Type 3 metabotropic glutamate receptors expressed by cancer stem cells as drug targets in the experimental treatment of malignant gliomas NEUROMED BIO Brain Disorders and ANTIOXIDANT TREATMENT TO PREVENT BIOMEDICAL HAZARDS OF CYCLIC VARIATIONS OF SOLAR ACTIVITY SAN DONATO BIO Endocrinology, Metabolism, Nutrition and Reproductive Sciences 13, Effect of telemedicine on Haemophilia Management, Treatment Effectiveness and Patient's Quality of Life Abruzzo CLI Healthcare Delivery and 14, Calcium handling proteins common gene variants for the prediction of life threatening arrhythmias in ICD recipients with heart failure NEUROMED BIO Cardiovascular and Development of pre operative investigation tools and surgical procedures for the treatment of movement disorders in childhood OSPEDALE BAMBINO GESU' BIO Brain Disorders and Comparison of next generation sequencing based identification of translocations with copy number alteration based identification of deletions for the development of patient/tumor specific real time PCR assays for detection of minimal residual disease usin IRCCS AOU San Martino IST (Genova) CLI Oncology 2 Translational 16, Pagina 4 di 6

5 Development of a miniaturized, automated assay for the diagnosis of rare diseases Piemonte BIO Bioengineering Sciences and Technologies Intensive nutritional counseling in cancer patients undergoing radiotherapy: a randomized controlled trial. SAN MATTEO CLI Oncology 2 Translational InTeReSt Project. Integrated Tecnological Rehabilitation of Stroke. Upper limb rehabilitation: efficacy of robot versus neuromodulation treatment and assessment of adaptive central peripheral plasticity DON GNOCCHI CLI Emerging Technologies and Training in s Honey and other hive products free from pharmaceutical or environmental residues: innovative, automated honey bee farming system Istituto Zooprofilattico Sperimentale del Lazio e della Toscana BIO Veterinary early detection of cardiotoxicity in cancer patients ONCOLOGICO DI BARI CLI Cardiovascular and 18, The overexpression of ANGPTL4 is involved in the inhibition of proliferation of human gastric cancer cell line MKN 45. Study of the effects of ANGPTL4 in invasiveness and metastasis. Development of effective approach for cancer therapy. PASCALE BIO Oncology 1 Basic Translational 19, Laser Treatment of Haemophilic Hypertrophic Synovia Toscana CLI Musculoskeletal, Oral and 20, Study and control of anticipatory movements followed to adaptation of sequential learned motorial gestures related to subjects intensively trained: FMRI and DTMRI study NEUROLESI BIO Integrative, Functional, and Cognitive Impact assessment of Training Centre for Integrated Health Emergency Emilia Romagna CLI Healthcare Delivery and Project title: Safety and Effectiveness of H.E.L.P. apheresis in microcirculatory diseases refractory to standard care Emilia Romagna CLI Cardiovascular and 21, Pagina 5 di 6

6 "Preventative strategies against dementia: clinical, biological and anthropological impact of long term treatment with anti oxidants in mild cognitive impairment" Umbria CLI Brain Disorders and 23, LEGENDA NOTE: NOTA 1 = Il PI del Progetto ha richiesto un finanziamento inferiore a quello minimo previsto dal Bando NOTA 2 = Principal Investigator non è operatore SSN NOTA 3 = Il Progetto è risultato uguale ad altro progetto presentato nello stesso Bando anche se in altra sezione Pagina 6 di 6

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2010 RICERCA FINALIZZATA Elenco Progetti Cofinanziati dall'industria Presentati 2304432 Calcium

More information

RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento

RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE. Graduatoria e Finanziamento Direzione Generale Ricerca Scientifica e Tecnologica RICERCA FINALIZZATA+GIOVANI RICERCATORI MALATTIE RARE Graduatoria e Finanziamento Ministero della Salute Direzione Generale Ricerca Scientifica e Tecnologica

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale della Ricerca e dell' Innovazione in Sanità BANDO 2013 PROGRAMMI DI RETE FINANZIATI PROGRAMMA NETWORK CODICE: 02356160 SCORE MEDIO DEL NETWORK: 13,75 Pediatric

More information

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF ALLIED HEALTH SCIENCES FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes

More information

Elenco dei periodici elettronici in Ovid Full text

Elenco dei periodici elettronici in Ovid Full text Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2010 GIOVANI RICERCATORI e RICERCA FINALIZZATA Tutte le Sezioni 2320870 2306996 2309719 2312984

More information

The following information is only meant for people who have been diagnosed with advanced non-small cell

The following information is only meant for people who have been diagnosed with advanced non-small cell Important information for people with advanced non-small cell lung cancer The following information is only meant for people who have been diagnosed with advanced non-small cell lung cancer (NSCLC). NSCLC

More information

Cytotoxic and Biotherapies Credentialing Programme Module 2

Cytotoxic and Biotherapies Credentialing Programme Module 2 Cytotoxic and Biotherapies Credentialing Programme Module 2 1. The Cell Cycle 2. Cancer Therapies 3. Adjunctive Therapies On completion of this module the RN will State the difference between a normal

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2010 RICERCA FINALIZZATA GRADUATORIA PROGETTI ORDINARI 2314291 Role of circulating and tissutal

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.

More information

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2010 GIOVANI RICERCATORI e RICERCA FINALIZZATA Tutte le Sezioni 2320870 RODDI New Robotic Platform

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Healthcare services requiring prior authorisation

Healthcare services requiring prior authorisation Annex 2 Healthcare requiring prior authorisation This list does not include organ transplants and does also not apply to long-term care and the primary purpose of which is to support people in need of

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA

Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA Determination of Biomarker Response in a Phase II Window of Opportunity Study of Defactinib (VS 6063), a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Resectable Malignant Pleural Mesothelioma

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

New strategies in anticancer therapy

New strategies in anticancer therapy 癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH

By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH By Dr. Mindy Aisen CEO and Director United Cerebral Palsy Research and Educational Foundation www.ucpresearch.org CEREBRAL PALSY RESEARCH Main Sources of Federal Funding for Cerebral Palsy and Disability

More information

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.

HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health. HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE Field Name Description Translational Research Mortality Analysis Join University-Conselleria Unit for Translational Research in the health

More information

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including

More information

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.

Brain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them. Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors

More information

Targeted Therapies in Lung Cancer

Targeted Therapies in Lung Cancer Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why

More information

Asteron Life Business Insurance

Asteron Life Business Insurance Asteron Life Business Insurance What lump sum covers are available with Asteron Life Business Insurance? Life Cover Life Cover pays a lump sum of money if you pass away or become terminally ill. Total

More information

Education Program Curriculum

Education Program Curriculum Academy of Life Underwriting Education Program Curriculum ALU CURRICULUM The ALU curriculum offers study materials and a series of ALU exams which allow a student to gain a broad understanding of the requirements

More information

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application

More information

Medical Specialties Guide

Medical Specialties Guide Medical Specialties Guide Allergy And Immunology Specialists in this field treat disorders related to how the body reacts to foreign substances. They treat such things as seasonal allergies, eczema, asthma,

More information

METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188

METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188 METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188 POLICYHOLDER: NORFOLK PUBLIC SCHOOLS Group Policy Form No: GPNP04-CI (Referred to herein as the Group Policy ) Certificate

More information

Classical drug resistance in the molecular age

Classical drug resistance in the molecular age Classical drug resistance in the molecular age Robert O Connor, Ph.D. Senior Programme Leader, Translational Cancer Pharmacology Lecturer in Biological Sciences, School of Nursing Chair ICORG Translational

More information

Enhancements to OneCare Product updates

Enhancements to OneCare Product updates Enhancements to Product updates INSURANCE September 2013 Your policy is now even better. Here s what the upgrades mean for you. Your policy includes a guarantee of upgrade. That means that when we improve

More information

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in

More information

REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM

REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM REPORT PERSPECTIVES IN LUNG CANCER 2010 AMSTERDAM Valerie Van Damme, Isabelle Wauters, Johan Vansteenkiste Univ. Hospital Leuven and Leuven Lung Cancer Group Introduction Perspectives in Lung Cancer (PILC)

More information

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns July 2013 Edition Vol. 7, Issue 7 Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns By Julie Katz, MPH, MPhil Biomarkers played a prominent role in the research presented in

More information

targeted therapy a guide for the patient

targeted therapy a guide for the patient targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

OMA Group Critical Illness Insurance - Covered condition definitions

OMA Group Critical Illness Insurance - Covered condition definitions OMA Group Critical Illness Insurance - Covered condition definitions The term diagnosis shall mean the diagnosis of a covered condition by a licensed physician (other than the insured, the insured s relative

More information

TRACKS GENETIC EPIDEMIOLOGY

TRACKS GENETIC EPIDEMIOLOGY Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that

More information

Cellular, Molecular, and Biochemical Targets in Breast Cancer

Cellular, Molecular, and Biochemical Targets in Breast Cancer Cellular, Molecular, and Biochemical Targets in Breast Cancer Kristy Kummerow Ingrid Meszoely December 12, 2012 VUMC Resident Bonus Conference One size fits all surgical treatment of breast cancer Wilhelm

More information

Cetuximab (Erbitux) MM.04.005 05/10/2005. HMO; PPO; QUEST Integration 01/01/2015 Section: Prescription Drugs Place(s) of Service: Office: Outpatient

Cetuximab (Erbitux) MM.04.005 05/10/2005. HMO; PPO; QUEST Integration 01/01/2015 Section: Prescription Drugs Place(s) of Service: Office: Outpatient Cetuximab (Erbitux) Policy Number: Original Effective Date: MM.04.005 05/10/2005 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 01/01/2015 Section: Prescription Drugs Place(s)

More information

Employee Critical Illness Option

Employee Critical Illness Option ECIO Employee Critical Illness Option Financial Protection for the Unexpected Includes Cancer Benefit First Occurrence Additional Occurrence Reoccurrence Spouse Coverage Available Child Coverage at No

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer

More information

Nuevas tecnologías basadas en biomarcadores para oncología

Nuevas tecnologías basadas en biomarcadores para oncología Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS

More information

Term Critical Illness Insurance

Term Critical Illness Insurance Term Critical Illness Insurance PRODUCT GUIDE 5368-01A-JUL14 ASSUMPTION LIFE This document is a summary of the various features of Assumption Life's products. It is neither a contract nor an insurance

More information

Genetics BRCA1 and BRCA2 are gene mutations which give 5 percent genetic risk of breast and ovary cancers. Worse if they drink alcohol.

Genetics BRCA1 and BRCA2 are gene mutations which give 5 percent genetic risk of breast and ovary cancers. Worse if they drink alcohol. Cancer seminar Ginseng & Dang Gui 10 Chinese formula to help cancer patients with energy. Cell Protect Green tea and turmeric increases efficacy as it helps cancer drugs to stay in cell i.e. reduce drug

More information

AI CPT Codes. x x. 70336 MRI Magnetic resonance (eg, proton) imaging, temporomandibular joint(s)

AI CPT Codes. x x. 70336 MRI Magnetic resonance (eg, proton) imaging, temporomandibular joint(s) Code Category Description Auth Required Medicaid Medicare 0126T IMT Testing Common carotid intima-media thickness (IMT) study for evaluation of atherosclerotic burden or coronary heart disease risk factor

More information

Emerging Drug List GEFITINIB

Emerging Drug List GEFITINIB Generic (Trade Name): Manufacturer: Gefitinib (Iressa ) formerly referred to as ZD1839 AstraZeneca NO. 52 JANUARY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence:

More information

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi Cancer SBL101 James Gomes School of Biological Sciences Indian Institute of Technology Delhi All Figures in this Lecture are taken from 1. Molecular biology of the cell / Bruce Alberts et al., 5th ed.

More information

Specialty Clinic Phone Listing

Specialty Clinic Phone Listing Adult Specialties Addiction Services (see Behavioral Health & Recovery/AODA) Allergy/Immunology 451 Junction Rd., Madison (West ) 263-6180 (local) 800-489-6008 (outreach clinics) 20 S. Park St., Madison

More information

E UROPEAN PERSONAL INFORMATION

E UROPEAN PERSONAL INFORMATION E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale della Ricerca e dell' Innovazione in Sanità BANDO 2013 PROGETTI BIOMEDICI FINANZIATI (escluso Programmi di Rete) Progetti con Cofinanziamento Industriale CO 2013

More information

Curriculum Vitae - Sara Gandini

Curriculum Vitae - Sara Gandini Curriculum Vitae - Sara Gandini Academic information 2004 PHD IN CANCER STUDIES at the University of Birmingham (Public Health), UK. Thesis: Meta-Analysis in Cancer Epidemiology. 1995 MASTER OF SCIENCE

More information

Asteron Life Personal Insurance

Asteron Life Personal Insurance Asteron Life Personal Insurance What lump sum covers are available with Asteron Life Personal Insurance? Life Cover Life Cover insurance pays a lump sum of money if you pass away or become terminally ill.

More information

Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART

Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART Harmesh Naik, MD. Hope Cancer Clinic HOW DO I MANAGE STAGE 4 NSCLC IN 2012: STATE OF THE ART Goals Discuss treatment options for stage 4 lung cancer: New and old Discuss new developments in personalized

More information

Cancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery

Cancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery Cancer treatment TOP EUROPEAN CANCER EXPERTISE The path to recovery 0% LAND OF HIGH QUALITY HEALTHCARE Located in Finland, a land of high quality healthcare, Helsinki University Hospital is regarded as

More information

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

Enjoy a position of vantage, come what may.

Enjoy a position of vantage, come what may. Enjoy a position of vantage, come what may. prucrisis covervantage While you have achieved much in life and you and your family enjoy the benefits of success, there may be times when the unexpected happens.

More information

Cancer Treatments Subcommittee of PTAC Meeting held 2 March 2012. (minutes for web publishing)

Cancer Treatments Subcommittee of PTAC Meeting held 2 March 2012. (minutes for web publishing) Cancer Treatments Subcommittee of PTAC Meeting held 2 March 2012 (minutes for web publishing) Cancer Treatments Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology

More information

BANDO MALATTIE RARE - AREA C. IN VERDE I PROGETTI FINANZIATI 1 di 6

BANDO MALATTIE RARE - AREA C. IN VERDE I PROGETTI FINANZIATI 1 di 6 Total Request 1 RF-FVG-2008-1203207 Clinical history and long-term costeffectiveness of Enzyme Replacement Therapy (ERT) for Gaucher Disease in Italy Friuli-Venezia Giulia 250.000,00 1.135.300,00 503.500,00

More information

Oregon CPT Preapproval Grid

Oregon CPT Preapproval Grid * The following grid only identifies items that require preapproval from. Breast Pumps Notes: No preapproval required for 1st month rental; beyond one month rental requires preapproval Genetic Testing

More information

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference Two New Clinical Programs and Significant Expansion of Cancer Pipeline Planned for 2004 SOUTH SAN FRANCISCO, Calif., Jan. 13 /PRNewswire-FirstCall/

More information

How To Become A Physio And Rehabilitation Medicine Specialist

How To Become A Physio And Rehabilitation Medicine Specialist EUROPEAN BOARD OF PHYSICAL AND REHABILITATION MEDICINE LOGBOOK EUROPEAN UNION OF MEDICAL SPECIALISTS UEMS IDENTIFICATION... 2 INSTRUCTIONS FOR USE... 3 THE TRAINING COURSE... 3 TRAINING PROGRAMME... 4

More information

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Irene Catucci 1,2,12, Paolo Verderio 3,12, Sara Pizzamiglio 3,12, Siranoush Manoukian 4, Bernard Peissel 4, Daniela Zaffaroni

More information

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN

Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification

More information

Zurich Life Risk Trauma cover

Zurich Life Risk Trauma cover Product Summary Issued 21 December 2015 Zurich Life Risk Trauma cover Adviser use only Trauma insurance provides a lump sum payment on diagnosis or occurrence of a covered trauma. This is a summary only

More information

School of Nursing and Midwifery. School of Nutritional Sciences and Dietetics

School of Nursing and Midwifery. School of Nutritional Sciences and Dietetics ABOUTTUMS Tehran University of Medical Sciences is the oldest and most well-known medical center in Iran. It is one of the country s top research universities which accepts applications from the most qualified

More information

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

JUMISC JUMISC. For further information visit our website:

JUMISC JUMISC. For further information visit our website: STEM CELL THERAPY COMPANY PROFILE & SCIENTIFIC ACTIVITIES For further information visit our website: WWW.CCMIJESUSUSON.COM 20 14 JUMISC JUMISC Carretera N-521, km. 41,8 10071 CÁCERES (SPAIN) Tel. (+34)

More information

Understanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient

Understanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that

More information

Breast Cancer. Breast Cancer Page 1

Breast Cancer. Breast Cancer Page 1 Breast Cancer Summary Breast cancers which are detected early are curable by local treatments. The initial surgery will give the most information about the cancer; such as size or whether the glands (or

More information

ITT Advanced Medical Technologies - A Programmer's Overview

ITT Advanced Medical Technologies - A Programmer's Overview ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,

More information

Where do we come from?

Where do we come from? ESCAP 13 International Congress Bridging the Gaps School integration as community care: the italian model Florence, 28 August 2007 Maria Antonella Costantino*, Giancarlo Onger, Dante Besana** *Director,

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

4.11 Healthcare Technology Co-operatives Version 4 (July 2015)

4.11 Healthcare Technology Co-operatives Version 4 (July 2015) HEALTHCARE TECHNOLOGY CO-OPERATIVES Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out

More information

RICERCA FINALIZZATA+GIOVANI RICERCATORI AREA BIOMEDICA. Graduatoria e Finanziamento

RICERCA FINALIZZATA+GIOVANI RICERCATORI AREA BIOMEDICA. Graduatoria e Finanziamento Direzione Generale Ricerca Scientifica e Tecnologica RICERCA FINALIZZATA+GIOVANI RICERCATORI AREA BIOMEDICA Graduatoria e Finanziamento Ministero della Salute Direzione Generale Ricerca Scientifica e

More information

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer Breast Studies Adjuvant therapy after surgery Her 2 positive Breast Cancer B 52 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients with Hormone

More information

Resumen Curricular de los Profesores. Jesse Boehm

Resumen Curricular de los Profesores. Jesse Boehm Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub

More information

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Most adults who qualify for the Medicaid category known as the Other Adult Group receive services under the New

More information

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE. NURS 202 Medical-Surgical Nursing II

STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE. NURS 202 Medical-Surgical Nursing II STATE UNIVERSITY OF NEW YORK COLLEGE OF TECHNOLOGY CANTON, NEW YORK COURSE OUTLINE NURS 202 Medical-Surgical Nursing II Prepared By: Brenda Worley and Mary Ann Caswell SCHOOL OF SCIENCE, HEALTH AND CRIMINAL

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Ministero della Salute

Ministero della Salute Ministero della Salute Direzione Generale Ricerca Sanitaria e Biomedica e della Vigilanza sugli Enti BANDO 2011 2012 GIOVANI RICERCATORI GRADUATORIA PROGETTI 02348313 Role of Polycomb Repressive Complexes

More information

LOOKING FORWARD PUMA BIOTECHNOLOGY, INC. 2014 ANNUAL REPORT

LOOKING FORWARD PUMA BIOTECHNOLOGY, INC. 2014 ANNUAL REPORT LOOKING FORWARD PUMA BIOTECHNOLOGY, INC. 2014 ANNUAL REPORT Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of

More information

National Horizon Scanning Centre. Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer. December 2007

National Horizon Scanning Centre. Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer. December 2007 Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer December 2007 This technology summary is based on information available at the time of research and a limited literature search.

More information

OVID (LWW) MEDICAL LIST

OVID (LWW) MEDICAL LIST OVID (LWW) MEDICAL LIST S.No. ProdDesc Primary Category 1. AACN: Advanced Critical Care Critical Care 2. Academic Internal 3. ACSM's Health & Fitness Journal Sports 4. Addictive Disorders & Their Treatment

More information

Progressive Care Insurance for life A NEW TYPE OF INSURANCE

Progressive Care Insurance for life A NEW TYPE OF INSURANCE Progressive Care Insurance for life A NEW TYPE OF INSURANCE New Progressive Care from Sovereign Progressive Care is a type of insurance that is new to New Zealand. It s not a traditional all-or-nothing

More information

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland

More information

Our Facility. Advanced clinical center with the newest and highly exact technology for treatment of patients with cancer pencil beam

Our Facility. Advanced clinical center with the newest and highly exact technology for treatment of patients with cancer pencil beam PTC Czech The main goal of radiotherapy is to irreversibly damage tumor cells, whereas the cells of healthy tissue are damaged only reversibly or not at all. Proton therapy currently comes closest to this

More information

STEM CELL FELLOWSHIP

STEM CELL FELLOWSHIP Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell

More information

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3 Elite coverage can help protect your savings. USAble Life s 1 coverage helps protect your family from the financial impact that can occur as the result of a heart attack, stroke or even cancer by providing

More information

E UROPEAN CURRICULUM VITAE FORMAT

E UROPEAN CURRICULUM VITAE FORMAT E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto

More information

Master of Physician Assistant Studies Course Descriptions for Year I

Master of Physician Assistant Studies Course Descriptions for Year I FALL TERM COURSES: Master of Physician Assistant Studies Course Descriptions for Year I PHAC 7230 Fundamentals in Pharmacology for Health Care I Credit Hrs: 3 This course will build on foundational knowledge

More information

Initial results of treatment with Linear Shockwave Therapy (LSWT) by Renova in patients with Erectile Dysfunction A pilot clinical study

Initial results of treatment with Linear Shockwave Therapy (LSWT) by Renova in patients with Erectile Dysfunction A pilot clinical study Initial results of treatment with Linear Shockwave Therapy (LSWT) by Renova in patients with Erectile Dysfunction A pilot clinical study Investigators Dr. Ahmed Hind, MD Consultant to Pr.Catanzaro Milano

More information

Renal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology)

Renal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) QUEENSWAY CARLETON HOSPITAL DIVISION OF UROLOGY NEPEAN, ON, CANADA Disclosures None Objectives Advances in the field of Renal Cell

More information